The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Energy Balance, Host-Related Factors, and Cancer Progression
Open accessAbstract
Obesity is associated with an increased risk and worsened prognosis for many types of cancer, but the mechanisms underlying the obesity–cancer progression link are poorly understood. Several energy balance–related host factors are known to influence tumor progression and/or treatment responsiveness after cancer develops, and these have been implicated as key contributors to the complex effects of obesity on cancer outcome. These host factors include leptin, adiponectin, steroid hormones, reactive oxygen species associated with inflammation, insulin, insulin-like growth factor–1, and sirtuins. Each of these host factors is considered in this article in the context of energy balance and cancer progression. In addition, future research directions in this field are discussed, including the importance of study designs addressing energy balance across the life course, the development and application of highly relevant animal models, potential roles of cancer stem cells in the response to energy balance modulation, and emerging pharmacologic approaches that target energy balance–related pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Uterine and prostate cancers provide additional examples of hormone-responsive tumors showing worse prognosis in obese patients.(1) An emerging issue in this area is the relative effects of nature versus nurture (ie, the contributions of systemic factors [lsbq]which have been the focus of this review] in the context o…”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“Activated macrophages exhibit either a classic proinflammatory M1 phenotype or an immunosuppressive M2 phenotype depending on the cytokine and chemokine environments.(33,34)”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Oxidative DNA damage: mechanisms, mutation, and disease
Cooke, M. S., Evans, M. D., Dizdaroglu, M., & Lunec, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0752rev · Cited by 3,245
Motzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61039-9 · Cited by 3,019
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · cited 2×
“From a mechanistic viewpoint, the binding of insulin (or IGF-1, which exerts similar effects) to cell-surface receptors on tumors or precancerous cells activates the P13K/Akt pathway, leading to downstream activation of the mammalian target of rapamycin (mTOR) complex, which serves as a central regulator of cell growt…”
BackgroundEGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Role of oxygen radicals in DNA damage and cancer incidence
Valko, M., Izakovic, M., Mazur, M., Rhodes, C. J., & Telser, J. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000049134.69131.89 · Cited by 1,820
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
Lin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775
Biochemistry and pathology of radical-mediated protein oxidation
DEAN, R. T., FU, S., STOCKER, R., & DAVIES, M. J. (1997) · Biochemical Journal · doi:10.1042/bj3240001 · Cited by 1,683
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241 · cited 1×
“Activated macrophages exhibit either a classic proinflammatory M1 phenotype or an immunosuppressive M2 phenotype depending on the cytokine and chemokine environments.(33,34)”
BackgroundThe worldwide obesity epidemic
James, P. T., Leach, R., Kalamara, E., & Shayeghi, M. (2001) · Obesity Research · doi:10.1038/oby.2001.123 · Cited by 1,201
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks, R., Lukanova, A., & Kurzer, M. S. (2002) · PubMed · Cited by 1,181
Signals That Regulate Food Intake and Energy Homeostasis
Woods, S. C., Seeley, R. J., Porte, D., & Schwartz, M. W. (1998) · Science · doi:10.1126/science.280.5368.1378 · Cited by 1,169
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005) · Science · doi:10.1126/science.1117728 · Cited by 1,107 · cited 1×
“SIRT1 has been shown to play a role in regulation of adiponectin,(92,93) insulin secretion, plasma glucose levels, and insulin sensitivity(94,95) and regulation of oxygen consumption and mitochondrial capacity.(96,97) Another yeast Sir2 homolog, mammalian SIRT3, has been shown to be selectively downregulated at both t…”
BackgroundThe LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1α
Nemoto, S., Fergusson, M. M., & Finkel, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501485200 · Cited by 1,047
Lumeng, C. N., DeYoung, S. M., Bodzin, J. L., & Saltiel, A. R. (2007) · Diabetes · doi:10.2337/db06-1076 · Cited by 1,016
Roux, C. W. L., Aylwin, S. J. B., Batterham, R. L., Borg, C. M., Coyle, F., Prasad, V., Shurey, S., Ghatei, M. A., Patel, A. G., & Bloom, S. R. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000183349.16877.84 · Cited by 985 · cited 1×
“Bariatric surgery, targeted at weight reduction, has significant hormonal effects, including control of many components of metabolic syndrome.(112) Bariatric surgery has been shown to reduce cancer mortality,(113) but its ability to decrease cancer progression in obese patients with established diagnoses of cancer has…”
BackgroundDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Cancer risk and oxidative DNA damage in man
Loft, S., & Poulsen, H. E. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00207507 · Cited by 945
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“In a recent study of patients receiving neoadjuvant chemotherapy for breast cancer, a group of women who were also treated with metformin for coexisting diabetes showed a greater rate of pathologic response.(136) Agents such as metformin that indirectly target the mTOR complex hold great promise, because mTOR serves a…”
BackgroundAdvances in protein kinase B signalling: AKTion on multiple fronts
Brazil, D. P., Yang, Z.-Z., & Hemmings, B. A. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.006 · Cited by 830
Sjöström, L., Gummesson, A., Sjöström, C. D., Narbro, K., Peltonen, M., Wedel, H., Bengtsson, C., Bouchard, C., Carlsson, B., Dahlgren, S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70159-7 · Cited by 770
Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae
Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O., & Sinclair, D. A. (2003) · Nature · doi:10.1038/nature01578 · Cited by 736
Bråkenhielm, E., Veitonmäki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B., Funahashi, T., & Cao, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308671100 · Cited by 732
SIRT1 transgenic mice show phenotypes resembling calorie restriction
Bordone, L., Cohen, D., Robinson, A., Motta, M. C., Van Veen, E., Czopik, A., Steele, A. D., Crowe, H., Marmor, S., Luo, J., et al. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00335.x · Cited by 722
PI3K/Akt: getting it right matters
Franke, T. F. (2008) · Oncogene · doi:10.1038/onc.2008.313 · Cited by 695
Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses
Chen, W. Y., Wang, D. H., Yen, R. C., Luo, J., Gu, W., & Baylin, S. B. (2005) · Cell · doi:10.1016/j.cell.2005.08.011 · Cited by 648
Hess, G., Herbrecht, R., Romaguera, J., Verhoef, G., Crump, M., Gisselbrecht, C., Laurell, A., Offner, F., Strahs, A., Berkenblit, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7977 · Cited by 641
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002020 · Cited by 588
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Corradetti, M. N., Inoki, K., Bardeesy, N., DePinho, R. A., & Guan, K.-L. (2004) · Genes & Development · doi:10.1101/gad.1199104 · Cited by 560
Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans
Hursting, S. D., Lavigne, J. A., Berrigan, D., Perkins, S. N., & Barrett, J. C. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152156 · Cited by 556
Self-citationPlasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
Giovannucci, E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.836s · Cited by 531
An expanding role for mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.007 · Cited by 523
DBC1 is a negative regulator of SIRT1
Kim, J.-E., Chen, J., & Lou, Z. (2008) · Nature · doi:10.1038/nature06500 · Cited by 505
Spector, N. L., & Blackwell, K. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1507 · Cited by 497
Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
Wei, E. K., Giovannucci, E., Fuchs, C. S., Willett, W. C., & Mantzoros, C. S. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji376 · Cited by 492
mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancer
Dann, S. G., Selvaraj, A., & Thomas, G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.04.002 · Cited by 481
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Recent advances in understanding leptin signaling and leptin resistance
Morris, D. L., & Rui, L. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00274.2009 · Cited by 470
Tumours with PI3K activation are resistant to dietary restriction
Kalaany, N. Y., & Sabatini, D. M. (2009) · Nature · doi:10.1038/nature07782 · Cited by 468
Mouse xenograft models vs GEM models for human cancer therapeutics
Richmond, A., & Su, Y. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000976 · Cited by 467
Negative regulation of the deacetylase SIRT1 by DBC1
Zhao, W., Kruse, J.-P., Tang, Y., Jung, S. Y., Qin, J., & Gu, W. (2008) · Nature · doi:10.1038/nature06515 · Cited by 466
Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Cowey, S., & Hardy, R. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051090 · Cited by 431
SIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer
Huffman, D. M., Grizzle, W. E., Bamman, M. M., Kim, J.-S., Eltoum, I. A., Elgavish, A., & Nagy, T. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0085 · Cited by 430
Giovannucci, E. L., Pollak, M., Platz, E. A., Willett, W. C., Stampfer, M. J., Majeed, N., Colditz, G. A., Speizer, F. E., & Hankinson, S. E. (2000) · PubMed · Cited by 401
Qiao, L., & Shao, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607215200 · Cited by 381
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue, F., & Michels, K. B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.823s · Cited by 353
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence
Barb, D., Williams, C. J., Neuwirth, A. K., & Mantzoros, C. S. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.858s · Cited by 338
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 329
Ramsey, K. M., Mills, K. F., Satoh, A., & Imai, S. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00355.x · Cited by 321
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 320
mTOR, translational control and human disease
Tee, A. R., & Blenis, J. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.11.005 · Cited by 320
Obesity and colon cancer: Does leptin provide a link?
Stattin, P., Lukanova, A., Biessy, C., Söderberg, S., Palmqvist, R., Kaaks, R., Olsson, T., & Jellum, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.11668 · Cited by 319
Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer
Loi, S., Milne, R. L., Friedlander, M. L., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Phillips, K.-A. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0042 · Cited by 319
Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy
Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 314
Cancer-Specific Functions of SIRT1 Enable Human Epithelial Cancer Cell Growth and Survival
Ford, J., Jiang, M., & Milner, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1923 · Cited by 298
AMPK as a mediator of hormonal signalling
Lim, C. T., Kola, B., & Korbonits, M. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0063 · Cited by 298
Adiponectin Secretion Is Regulated by SIRT1 and the Endoplasmic Reticulum Oxidoreductase Ero1-L α
Qiang, L., Wang, H., & Farmer, S. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02279-06 · Cited by 290
The Systemic Reaction During Inflammation: The Acute-Phase Proteins
Ceciliani, F., Giordano, A., & Spagnolo, V. (2002) · Protein & Peptide Letters · doi:10.2174/0929866023408779 · Cited by 285
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Jiang, B.-H., & Liu, L.-Z. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.03.001 · Cited by 243
Gonzalez, R. R., Cherfils, S., Escobar, M., Yoo, J. H., Carino, C., Styer, A. K., Sullivan, B. T., Sakamoto, H., Olawaiye, A., Serikawa, T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601991200 · Cited by 242
Leptin signaling in breast cancer: An overview
Cirillo, D., Rachiglio, A. M., la Montagna, R., Giordano, A., & Normanno, N. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21911 · Cited by 235
Kagawa, Y. (1978) · Preventive Medicine · doi:10.1016/0091-7435(78)90246-3 · Cited by 234
Recent advances in cancer stem cells
Cho, R. W., & Clarke, M. F. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.017 · Cited by 227
Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease
Astrinidis, A., & Henske, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1209090 · Cited by 209
Hakimi, P., Yang, J., Casadesus, G., Massillon, D., Tolentino-Silva, F., Nye, C. K., Cabrera, M. E., Hagen, D. R., Utter, C. B., Baghdy, Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706127200 · Cited by 201
Metformin in Breast Cancer: Time for Action
Goodwin, P. J., Ligibel, J. A., & Stambolic, V. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1630 · Cited by 200
Circulating levels of leptin, adiposity and breast cancer risk
Wu, M.-H., Chou, Y.-C., Chou, W.-Y., Hsu, G.-C., Chu, C.-H., Yu, C.-P., Yu, J.-C., & Sun, C.-A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604913 · Cited by 195
Pothiwala, P., Jain, S. K., & Yaturu, S. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0065 · Cited by 187
Yang, T., Fu, M., Pestell, R., & Sauve, A. A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.04.002 · Cited by 183
Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancer
Lukanova, A., Zeleniuch‐Jacquotte, A., Lundin, E., Micheli, A., Arslan, A. A., Rinaldi, S., Muti, P., Lenner, P., Koenig, K. L., Biessy, C., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.11544 · Cited by 178
Cancer Stem Cells in Breast: Current Opinion and Future Challenges
Charafe-Jauffret, E., Monville, F., Ginestier, C., Dontu, G., Birnbaum, D., & Wicha, M. S. (2008) · Pathobiology · doi:10.1159/000123845 · Cited by 176
Jiang, W., Zhu, Z., & Thompson, H. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6721 · Cited by 174
Bastarrachea, J., Hortobagyi, G. N., Smith, T. L., Kau, S.-W. C., & Buzdar, A. U. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00004 · Cited by 171
Physical Activity and Cancer Prevention: Pathways and Targets for Intervention
Rogers, C. J., Colbert, L. H., Greiner, J. W., Perkins, S. N., & Hursting, S. D. (2008) · Sports Medicine · doi:10.2165/00007256-200838040-00002 · Cited by 170
Self-citationMoore, T., Beltran, L., Carbajal, S., Strom, S., Traag, J., Hursting, S. D., & DiGiovanni, J. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0022 · Cited by 169
Self-citationEffect of family history, obesity and exercise on breast cancer risk among postmenopausal women
Carpenter, C. L., Ross, R. K., Paganini‐Hill, A., & Bernstein, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11186 · Cited by 164
The Redox Regulation of PI 3-Kinase–Dependent Signaling
Leslie, N. R. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1765 · Cited by 163
LeRoith, D., Novosyadlyy, R., Gallagher, E. J., Lann, D. E., Vijayakumar, A., & Yakar, S. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1081488 · Cited by 120
Reducing the weight of cancer: mechanistic targets for breaking the obesity–carcinogenesis link
Hursting, S. D., Lashinger, L. M., Wheatley, K. W., Rogers, C. J., Colbert, L. H., Núñez, N. P., & Perkins, S. N. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.08.009 · Cited by 119
Self-citationYechoor, V. K., Patti, M., Ueki, K., Laustsen, P. G., Saccone, R., Rauniyar, R. K., & Kahn, C. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407574101 · Cited by 114
Allen, N. E., Roddam, A. W., Allen, D., Fentiman, I., Silva, I. D. S., Peto, J., Holly, J. M. P., & Key, T. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602471 · Cited by 114
Height, Body Mass Index, and Physical Activity in Relation to Glioma Risk
Moore, S. C., Rajaraman, P., Dubrow, R., Darefsky, A. S., Koebnick, C., Hollenbeck, A. R., Schatzkin, A. G., & Leitzmann, M. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1669 · Cited by 113
Oxidative Stress, Obesity, and Breast Cancer Risk: Results From the Shanghai Women's Health Study
Dai, Q., Gao, Y.-T., Shu, X., Yang, G., Milne, G. L., Cai, Q., Wen, W., Rothman, N., Cai, H., Li, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7970 · Cited by 112
Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women
Michaud, D. S., Wolpin, B. M., Giovannucci, E. L., Liu, S., Cochrane, B. B., Manson, J. E., Pollak, M., Ma, J., & Fuchs, C. S. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0182 · Cited by 112
The Obesity-Cancer Link: Lessons Learned from a Fatless Mouse
Hursting, S. D., Nunez, N. P., Varticovski, L., & Vinson, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4237 · Cited by 110
Self-citationAnthropometric measures, plasma adiponectin, and breast cancer risk
Tian, Y.-F., Chu, C.-H., Wu, M.-H., Chang, C.-L., Yang, T., Chou, Y., Hsu, G., Yu, C., Yu, J., & Sun, C. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0089 · Cited by 106
Fenton, J. I., Hursting, S. D., Perkins, S. N., & Hord, N. G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl018 · Cited by 102
Self-citationSIRT1: Tumor promoter or tumor suppressor?
Lim, C. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.050 · Cited by 97
Physical Activity and Colon Cancer Risk among Women in the California Teachers Study
Mai, P. L., Sullivan‐Halley, J., Ursin, G., Stram, D. O., Deapen, D., Villaluna, D., Horn‐Ross, P. L., Clarke, C. A., Reynolds, P., Ross, R. K., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0747 · Cited by 95
SIRT1: Linking Adaptive Cellular Responses to Aging-Associated Changes in Organismal Physiology
Anastasiou, D., & Krek, W. (2006) · Physiology · doi:10.1152/physiol.00031.2006 · Cited by 94
Obesity Accelerates Mouse Mammary Tumor Growth in the Absence of Ovarian Hormones
Núñez, N. P., Perkins, S. N., Smith, N. C. P., Berrigan, D. A., Berendes, D. M., Varticovski, L., Barrett, J. C., & Hursting, S. D. (2008) · Nutrition and Cancer · doi:10.1080/01635580801966195 · Cited by 91
Self-citationFenton, J. I., Birmingham, J., Hursting, S. D., & Hord, N. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23436 · Cited by 89
Self-citationHursting, S. D., Switzer, B. R., French, J. E., & Kari, F. W. (1993) · PubMed · Cited by 88
Self-citationReversal of food restriction-induced inhibition of mouse skin tumor promotion by adrenalectomy
Pashko, L. L., & Schwartz, A. G. (1992) · Carcinogenesis · doi:10.1093/carcin/13.10.1925 · Cited by 87
Fenton, J. I., Hord, N. G., Lavigne, J. A., Perkins, S. N., & Hursting, S. D. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0916 · Cited by 83
Self-citationSchairer, C., Hill, D. A., Sturgeon, S. R., Fears, T. R., Pollak, M., Mies, C., Ziegler, R. G., Hoover, R. N., & Sherman, M. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11624 · Cited by 80
Aspirin and Colon Cancer — Targeting Prevention?
Markowitz, S. D. (2007) · New England Journal of Medicine · doi:10.1056/nejme078044 · Cited by 77
Treatment Resistance in Stem Cells and Breast Cancer
Dave, B., & Chang, J. C. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9117-9 · Cited by 75
Effects of adiponectin and leptin co-treatment on human breast cancer cell growth
Cleary (2009) · Oncology Reports · doi:10.3892/or_00000395 · Cited by 69
Moore, T., Carbajal, S., Beltrán, L., Perkins, S. N., Yakar, S., LeRoith, D., Hursting, S. D., & DiGiovanni, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6271 · Cited by 68
Self-citationCancer risk and oxidative DNA damage in man
Loft, S. H., & Poulsen, H. E. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050089 · Cited by 65
Takahashi, K., & Suzuki, K. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550322 · Cited by 62
Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia
Petridou, E. T., Dessypris, N., Spanos, E., Mantzoros, C. S., Skalkidou, A., Kalmanti, M., Koliouskas, D. E., Kosmidis, H. V., Panagiotou, J. P., Piperopoulou, F., et al. (1999) · International Journal of Cancer · Cited by 61
Associations Between Obesity and Changes in Adult BMI Over Time and Colon Cancer Risk
Nock, N. L., Thompson, C. L., Tucker, T. C., Berger, N. A., & Li, L. (2008) · Obesity · doi:10.1038/oby.2008.42 · Cited by 48
Self-citationJiang, W., Zhu, Z., Bhatia, N., Agarwal, R., & Thompson, H. J. (2002) · PubMed · Cited by 47
The role of sirtuin proteins in obesity
Metoyer, C. F., & Pruitt, K. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.04.002 · Cited by 40
Parekh, N., Okada, T., & Lu‐Yao, G. L. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2009.05.001 · Cited by 34
Birt, D. F., Przybyszewski, J., Wang, W., Stewart, J. W., & Liu, Y. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10741 · Cited by 22
Cited by
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
Pitt, J. M., Vétizou, M., Daillère, R., Roberti, M. P., Yamazaki, T., Routy, B., Lepage, P., Boneca, I. G., Chamaillard, M., Kroemer, G., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.001 · Cited by 1,041
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Fan, Y., Mao, R., & Yang, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2084-3 · Cited by 776
Energy balance and obesity: what are the main drivers?
On behalf of the IARC working group on Energy Balance and Obesity, Romieu, I., Dossus, L., Barquera, S., Blottière, H. M., Franks, P. W., Gunter, M., Hwalla, N., Hursting, S. D., Leitzmann, M., et al. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0869-z · Cited by 739
Self-citation
Metadata
- Authors
- Hursting, S. D., & Berger, N. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-09-10
- Volume
- 28
- Issue
- 26
- Pages
- 4058-4065
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1976028023
- Cited by
- 252
- References
- 136
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.